ArticleArquivos brasileiros de cardiologia2021

The Challenge of Incorporating High-Cost Technologies: An Analysis of PCSK9 Inhibitors.

Miriam Allein Zago Marcolino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.